Investing NewsBristol Myers Squibb Buys RayzeBio, Its Second Multibillion-Dollar Deal in DaysDecember 26, 2023 by admin 0 Comments Bristol Myers Squibb announced it was buying RayzeBio for $4.1 billion, its second multibillion- dollar acquisition in less than a week. Articles You May Like Alphabet Stock Sell Alert: Why It’s Time to Ditch Good Ol’ GOOG Christmas Comes Early: 3 Stocks at 52-Week Lows Set to Double by Year’s End Gamer’s Gold: 3 Stocks to Power Up Your Portfolio’s High Score 3 Oil & Gas Dividend Stocks to Own for a Lifetime of Income Wall Street Favorites: 3 Battery Stocks with Strong Buy Ratings for May 2024